Author

K. V. Giridhar

Observed names: K. Giridhar, K.V. Giridhar

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5126194673

Abstract PS5-01-16: Phase II Trial of the FASN Inhibitor, Denifanstat (TVB-2640), Plus Trastuzumab in Combination with Paclitaxel or Endocrine Therapy (ET) in Patients with HER2+ Metastatic Breast Cancer (MBC) Resistant to Trastuzumab

2026 · T. C. Haddad, V. J. Suman, et al. · Clinical Cancer Research · 1

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic

2026 · K.V. Giridhar, M.P. Goetz · Annals of Oncology

Abstract PS1-10-22: Tumor-infiltrating lymphocytes in advanced ER-positive, HER2-negative breast cancer prior to treatment with palbociclib and endocrine therapy: a retrospective analysis of the PROMISE study

2026 · C. C. O'Sullivan, A. M. Moyer, et al. · Clinical Cancer Research

Abstract PS4-03-10: Assessing the impact of real-time serial circulating tumor cell results on the management of patients with metastatic breast cancer

2026 · K. V. Giridhar, D. Zahrieh, et al. · Clinical Cancer Research

Abstract PS4-02-01: Differential early response to neoadjuvant endocrine therapy in lobular versus non-lobular breast cancer on the Endocrine Optimization Pilot (EOP) of the I-SPY2 Trial

2026 · R. Mukhtar, P. Norwood, et al. · Clinical Cancer Research

Abstract PD2-06: Molecular causes of subtype switching in primary and metastatic breast tumor pairs from the AURORA US Project

2026 · A. R. Michmerhuizen, B. M. Felsheim, et al. · Clinical Cancer Research

Abstract PS2-11-08: Stemness-targeted therapies to enhance the efficacy of AURKA inhibitors in endocrine resistant er+ breast cancer

2026 · A. B. D'ASSORO, M. Drago, et al. · Clinical Cancer Research

Abstract PD3-09: Molecular characterization of resistance to antibody drug conjugates in metastatic breast cancer: a prospective analysis from the AURORA US Network

2026 · A. C. Garrido-Castro, W. C. Nenad, et al. · Clinical Cancer Research

Abstract PS5-07-20: Trial in progress: Phase 1 Study Targeting DNA Methyltransferases in Metastatic Triple-Negative Breast Cancer (NCI Protocol #10546)

2026 · R. Leon-Ferre, D. M. Zahrieh, et al. · Clinical Cancer Research

Abstract PS3-07-10: Low dose (Z)-endoxifen in the I-SPY2 Endocrine Optimization Pilot

2026 · K. V. Giridhar, M. P. Goetz, et al. · Clinical Cancer Research

Abstract PS2-07-17: Characterizing circulating tumor cell (CTC) enumeration and phenotypic profiling in blood with synchronously obtained tissue in metastatic breast cancer (MBC) in TBCRC /AURORA US

2026 · K. V. Giridhar, W. C. Nenad, et al. · Clinical Cancer Research

Works count: 11

Citation count: 1

H-index: 1

I10-index: